Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Michael Porter , has served on our board of directors since the commencement of our listing on Nasdaq. Mr. Porter is a corporate finance and operational executive with over 25 years of experience spanning private equity, mergers and acquisitions, restructurings, and leadership across various sectors. Since 2025, Mr. Porter has served as founder and Managing Partner of a private direct investment family office focused on life sciences, commodities, and cash flow businesses. From 2015 to 2025, Mr. Porter served as Chief Executive Officer, Co -Founder , and member of the board of directors of Covis Pharma Group, a global branded pharmaceutical company and portfolio company of Cerberus Capital Management, L.P. (“Cerberus”) and subsequently Apollo Global Management, Inc. From 2013 to 2015, Mr. Porter served as Chief Operating Officer, Chief Financial Officer, and member of the board of directors of Covis Pharma Holdings Sàrl, a portfolio company of Cerberus.
This record is keyed to SEC CIK 0002143414 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row.